在妇科癌症中长非编码RNA多态.
Esmat Abdi1, Saeid Latifi-Navid1, Alireza Panahi1
1Department of Biology, Faculty of Sciences, University of Mohaghegh Ardabili, Ardabil, 5619911367, Iran.
Personalized medicine
|December 14, 2023
概括
长非编码RNA (lncRNA) 多态呈现出预测妇科癌症风险和指导个性化治疗的前景. 需要进一步的研究来证实这些发现在不同的人群中.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 妇科恶性瘤对癌症死亡率有显著的贡献.
- 目前针对这些癌症的治疗方法仍然不足,尽管治疗方面取得了进展.
- 长非编码RNAs (lncRNAs) 在细胞过程中起着至关重要的作用,如分化,增殖和亡,它们的失调与瘤发生有关.
研究的目的:
- 综合审查 lncRNA 多态性对妇科癌症的影响.
- 探索 lncRNA 变异在癌症风险评估和早期诊断中的潜力.
- 评估lncRNA多态性在为妇科恶性瘤开发个性化治疗策略中的作用.
主要方法:
- 在妇科癌症中调查lncRNA多态性的研究的文献综述.
- 分析单核酸多态 (SNP) 如何影响 lncRNA 功能和表达.
- 关于 lncRNA 变异对癌症风险和治疗的预测价值的证据综合.
主要成果:
- lncRNA多态性可以影响 lncRNA的表达和功能,从而导致癌症的发展.
- 特定的 lncRNA 变异显示出作为预测癌症风险的生物标志物的潜力.
- 这些遗传变异可能为妇科瘤学中早期检测和量身定制的治疗提供途径.
结论:
- lncRNA多态性与妇科癌症的发展和进展有关.
- 与lncRNA相关的变体有望改善癌症发病率评估,早期检测和个性化管理.
- 需要进一步的广泛研究来验证这些发现在更大,多样化的种族队列中.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
RNA Splicing
56.4K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.4K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
piRNA - Piwi-interacting RNAs
6.9K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.9K


